Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance
Post-prophylaxis surveillance significantly reduced CMV end-organ disease and resistance. Despite observing increased replication rates in the surveillance era, rejection was not significantly different and there was no graft loss or patient mortality at 12 months.
Authors
- Christopher M. Saddler (ORCID: https://orcid.org/0000-0002-6656-981X)
- Jeannina A. Smith (ORCID: https://orcid.org/0000-0001-9379-6332)
- Didier A. Mandelbrot (ORCID: https://orcid.org/0000-0003-3326-8583)
- Jillian L. Descourouez (ORCID: https://orcid.org/0000-0002-1196-5110)
- Margaret R. Jorgenson (ORCID: https://orcid.org/0000-0001-6088-9727)
- Jon S. Odorico (ORCID: https://orcid.org/0000-0003-1096-464X)
- Glen Leverson (ORCID: https://orcid.org/0000-0003-2286-3088)
- John P. Rice (ORCID: https://orcid.org/0000-0002-1462-6958)
- Ethan Meyer
Institutions
- University of Wisconsin–Madison (US)
- UW Health University Hospital (US)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1111/ctr.15453
- Citations
- 5
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 1.93